Lund Systemic Sclerosis Research Group
51 – 60 of 77
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Persistent elevation of fibrosis biomarker cartilage oligomeric matrix protein following hepatitis C virus eradication
(
- Contribution to journal › Article
-
Mark
Nailfold capillaroscopy-how many fingers should be examined to detect abnormality?
(
- Contribution to journal › Article
-
Mark
Validity of the Swedish version of the systemic sclerosis quality of life questionnaire (SSCQoL) : A novel measure of quality of life for patients with systemic sclerosis
(
- Contribution to journal › Letter
-
Mark
Decreased biventricular longitudinal strain in patients with systemic sclerosis is mainly caused by pulmonary hypertension and not by systemic sclerosis per se
(
- Contribution to journal › Article
-
Mark
Patientens perspektiv på att leva med PAH eller CTEPH i Sverige : Enkätstudie visar på betydelsen av adekvat och upprepad information
(
- Contribution to journal › Article
-
Mark
Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice : A prospective cohort study
(
- Contribution to journal › Article
-
Mark
Higher plasma fibroblast growth factor 23 levels are associated with a higher risk profile in pulmonary arterial hypertension
(
- Contribution to journal › Article
-
Mark
GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways
(
- Contribution to journal › Article
-
Mark
Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease
(
- Contribution to journal › Letter
- 2018
-
Mark
Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational Study
(
- Contribution to journal › Article